as on January 27, 2026 at 2:29 am IST
Day's Low
Day's High
11.69%
Downside
3.90%
Upside
52 Week's Low
52 Week's High
33.77%
Downside
127.27%
Upside
Check Rein Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$36.0M
EPS (TTM)
-0.955
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-83.28%
Compare market cap, revenue, PE, and other key metrics of Rein Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $36.0M | NA | NA | 0.00% | |
| BUY | $47.3B | 132.54% | 1234.41 | 1.36% | |
| BUY | $120.1B | 111.69% | 33.01 | 31.35% | |
| NA | $37.5B | NA | 665.33 | 1.38% | |
| BUY | $79.9B | 47.93% | 18.05 | 32.13% |
The Rein Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Rein Therapeutics Inc investment value today
Current value as on today
₹79,526
Returns
Returns from Rein Therapeutics Inc Stock
Dollar Returns*
₹6,193 (+6.19%)
Search interest for Rein Therapeutics Inc Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, RNTX stock has moved up by 29.2%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 50.0% return, outperforming this stock by 76.2%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 30.0% return, outperforming this stock by 76.0%
| Organisation | Rein Therapeutics Inc |
| Headquarters | 12407 N. Mopac Expy., Austin, TX, United States, 78758 |
| CEO | Dr. James Brian Windsor Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. James Brian Windsor Ph.D. | CEO, President & Director |
Mr. Timothy M. Cunningham CPA, M.B.A. | Interim CFO & Principal Accounting Officer |
Dr. Cory M. Hogaboam Ph.D. | Chief Scientific Officer |
Ms. Jennifer Faigle | Counsel |
Mr. Ron Chen | VP of Finance and Corporate Controller |
Rein Therapeutics Inc share price today is $1.54 as on at the close of the market. Rein Therapeutics Inc share today touched a day high of $1.6 and a low of $1.36.
Rein Therapeutics Inc share touched a 52 week high of $3.5 on and a 52 week low of $1.02 on . Rein Therapeutics Inc stock price today i.e. is closed at $1.54,which is 56.00% down from its 52 week high and 50.98% up from its 52 week low.
Rein Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Rein Therapeutics Inc (RNTX) shares with as little as ₹91.708 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.08 in Rein Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Rein Therapeutics Inc share’s latest price of $1.54 as on January 27, 2026 at 2:29 am IST, you will get 6.4935 shares of Rein Therapeutics Inc. Learn more about
fractional shares .